TITLE

INTERNET USE AND BREAST CANCER SURVIVORS

AUTHOR(S)
Muhamad, Mazanah; Afshari, Mojgan; Mohamed, Nor Aini
PUB. DATE
October 2011
SOURCE
Turkish Online Journal of Educational Technology;Oct2011, Vol. 10 Issue 4, p241
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A survey was administered to 400 breast cancer survivors at hospitals and support group meetings in Peninsular Malaysia to explore their level of Internet use and factors related to the Internet use by breast cancer survivors. Findings of this study indicated that about 22.5% of breast cancer survivors used Internet to get information about breast health issues. They had access to computer in their more personalized spaces such as at their home and in their workplace. Breast cancer survivors tended to use Internet to get information about cancer and treatment options especially on radiotherapy, chemotherapy, health management, treatment side effects and dietary practice. Majority of Internet users believed that information on the Internet were not useful to improve their knowledge about health care issues. Also, significant relationships exist between level of Internet use and five independent variables, including, age, education level, annual income, residence, and race/ethnicity. It is suggested that health care providers should realize how Web-based intervention programs can help breast cancer patients and then encourage patients to use Internet to get highly information to integrate them into their medical and psychological care.
ACCESSION #
71342760

 

Related Articles

  • Male breast cancer: temporal trends and treatment in Lithuania. Jackevičius, Algirdas; Šarakauskienė, Leonarda; Ostapenko, Valerijus; Kurtinaitis, Juozas; Bružas, Saulius; Mudėnas, Algimantas // Acta Medica Lituanica;2009, Vol. 16 Issue 3/4, p119 

    Male breast cancer is a rare disease in Lithuania, comprising less than 0.2% of malignancies among men. During the last decade, there has been no change in the frequency of the disease, with 10-15 cases registered every year during 1988-2006, and only 16 of the more than 8000 new cases in 2006...

  • Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study. Bengala, C.; Zamagni, C.; Pedrazzoli, P.; Matteucci, P.; Ballestrero, A.; Da Prada, G.; Martino, M.; Rosti, G.; Danova, M.; Bregni, M.; Jovic, G.; Guarneri, V.; Maur, M.; Conte, P. F. // British Journal of Cancer;4/10/2006, Vol. 94 Issue 7, p1016 

    HER-2 overexpression is associated to a poor prognosis in high-risk and metastatic breast cancer (MBC) patients treated with high-dose chemotherapy (HDC). HER-2 status is also a predictive factor and when trastuzumab is administered in combination with or sequentially to chemotherapy, a...

  • Exploring the differential experience of breast cancer treatment-related symptoms: a cluster analytic approach. Clement Gwede; Pamela Munster; Michael Andrykowski; Paul Jacobsen // Supportive Care in Cancer;Aug2008, Vol. 16 Issue 8, p925 

    Abstract Introduction  Cancer patients experience multiple concurrent symptoms. This exploratory analysis assessed symptom burden among patients undergoing chemotherapy for breast cancer to identify distinct subgroups of patients who experience differential symptom burden and assessed...

  • 'These people left their handprints on my heart' Yates-Bolton, Natalie // Nursing Standard;7/4/2012, Vol. 26 Issue 44, p22 

    Natalie Yates-Bolton celebrates the excellent care she received throughout her cancer journey.

  • Comparison of Long-Term Outcomes of Postmastectomy Radiotherapy between Breast Cancer Patients with and without Immediate Flap Reconstruction. Lee, Hsin-Hua; Hou, Ming-Feng; Wei, Shu-Yi; Lin, Sin-Daw; Luo, Kuei-Hau; Huang, Ming-Yii; Ou-Yang, Fu; Huang, Chih-Jen // PLoS ONE;2/10/2016, Vol. 11 Issue 2, p1 

    Purpose: To compare the long-term clinical outcomes of postmastectomy radiotherapy (PMRT) between breast cancer patients with and without immediate transverse rectus abdominis myocutaneous (TRAM) flap reconstruction. Methods: The study included 492 patients with stage II or III breast cancer...

  • Interrogating a Multifactorial Model of Breast Conserving Therapy with Clinical Data. Salmon, Remi; Garbey, Marc; Moore, Linda W.; Bass, Barbara L. // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Most women with early stage breast cancer do not require removal of the entire breast to treat their cancer; instead, up to 70% of women can be effectively and safely treated by breast conserving therapy (BCT) with surgical removal of the tumor only (lumpectomy) followed by radiation treatment...

  • Combine Treatments for Best Results.  // USA Today Magazine;Oct91, Vol. 120 Issue 2557, p4 

    Discusses the effectiveness of triple modality therapy for breast cancer. Radiation therapy; Systematic chemotherapy; Mastectomy; Increase survival rates; List of complications.

  • Accelerated IMRT with concurrent boost resulted in good local control, OS in breast cancer.  // Hem/Onc Today;11/10/2011, Vol. 12 Issue 21, p34 

    The article reports that a regimen of accelerated intensity-modulated radiation therapy (IMRT) with a concurrent boost to the tumor bed has resulted in good local control rate and overall survival (OS) in patients with breast cancer.

  • United States Trends in the Surgical Treatment of Primary Breast Cancer. Tuttle, Todd; Rueth, Natasha; Abbott, Andrea; Virnig, Beth // World Journal of Surgery;Jul2012, Vol. 36 Issue 7, p1475 

    The article discusses the evaluations of patterns in the treatment of breast cancer in the U.S. which focuses on trends such as mastectomy and the use of radiation therapy (RT). It says that the mastectomy rates increased from 2004's 35% to 60% in 2007. It mentions that the contralateral...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics